Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Centerstone Investors LLC

Centerstone Investors LLC lessened its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 27.2% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 51,991 shares of the company's stock after selling 19,383 shares during the quarter. Henry Schein makes up about 5.3% of Centerstone Investors LLC's portfolio, making the stock its 6th biggest holding. Centerstone Investors LLC's holdings in Henry Schein were worth $3,598,000 as of its most recent filing with the SEC.

A number of other large investors also recently added to or reduced their stakes in the stock. Olstein Capital Management L.P. increased its stake in shares of Henry Schein by 17.2% in the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock worth $7,543,000 after acquiring an additional 16,000 shares during the last quarter. Private Management Group Inc. increased its position in Henry Schein by 5.7% during the fourth quarter. Private Management Group Inc. now owns 350,515 shares of the company's stock worth $24,256,000 after purchasing an additional 18,882 shares during the last quarter. Equitable Trust Co. acquired a new stake in Henry Schein during the fourth quarter worth about $417,000. Savant Capital LLC raised its stake in Henry Schein by 43.9% during the fourth quarter. Savant Capital LLC now owns 4,651 shares of the company's stock worth $322,000 after purchasing an additional 1,420 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. boosted its holdings in Henry Schein by 29.9% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,854 shares of the company's stock valued at $1,113,000 after purchasing an additional 3,650 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Stock Performance

Shares of HSIC stock opened at $71.33 on Friday. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The company has a market cap of $8.68 billion, a P/E ratio of 29.35, a PEG ratio of 2.13 and a beta of 0.87. The firm has a fifty day moving average price of $67.46 and a 200 day moving average price of $71.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business's quarterly revenue was down .1% on a year-over-year basis. During the same quarter last year, the company earned $1.10 EPS. Sell-side analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently commented on the company. Piper Sandler decreased their price target on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 30th. Jefferies Financial Group raised their price target on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research report on Thursday, January 23rd. Wall Street Zen cut Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Barrington Research cut their price target on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 6th. Finally, Wells Fargo & Company reduced their price target on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $79.30.

Insider Transactions at Henry Schein

In related news, Director Philip A. Laskawy sold 2,604 shares of the firm's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the transaction, the director now owns 24,805 shares in the company, valued at $1,762,147.20. This trade represents a 9.50% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at $4,460,251.20. The trade was a 6.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.08% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.